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Doctors and the medical aid
industry
To the Editor: I respond to the comments of Dr Groenveld1
from what is so unfortunately branded ‘the other side’.
How sad that SAMA, the HPCSA, government, medical
aids, and the public all get berated by the learned writer.  How
naïve (with respect) to maintain that in a R50 billion private
health care industry, stakeholders as vital as doctors ‘should
not be required to be businessmen’.  If you aren’t, then don’t be
resentful if other stakeholders do treat it as a business.
This does not mean that the stakeholders should question
each other’s right to existence either, or treat health care as a
zero sum game where we all fight for a bigger slice.  We
shouldn’t aspire in South Africa to have the unregulated USA
model which consumes 15% of GNP and still leaves 40 million
uninsured, or the UK National Health where doctors are told
exactly what to do.
So, we don’t have a perfect system in South Africa, but let’s
at least move forward from adversarial finger-pointing,
without hankering after an unrealistic utopia of unbridled
freedom regardless of cost, which is not grounded in the reality
of working South Africans.
Solution?  Nothing simple — no right and wrong, but
pragmatic stakeholders forging partnership relationships to
work out a range of possibilities that give us greater access to
affordable, appropriate, cost-effective, quality care.
Let us give credit to those pioneering funders and
practitioners who have risked sacrificing the comfort of
armchair critic status in favour of the partly successful but
promising models upon which we can base our future
successes.  A decade after the early acrimonious engagements
we now find clinicians on both sides of the table representing
IPAs and managed care organisations — talks are still tough,
but no longer as naïve, arrogant or petulant.
I am not sure that our health care system can afford
anything other than all of us rolling up our sleeves and jointly
evolving workable answers.
Gary Taylor
Medscheme Head Office
10 Muswell Road
Bryanston, Gauteng
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Infant feeding and prevention of
mother-to-child HIV transmission
To the Editor: I fail to understand how your reviewer was
unable to recognise the fairly obvious flaws in the paper by
Hilderbrand et al.,1 and did not grasp the seriousness and
impact of such faulty data on public perceptions of infant
feeding. This error of judgement is compounded by the
Journal’s egregious running title on the cover stating: ‘HIV —
formula feeds increase child survival’. In fact the paper does
not have child survival or mortality as an outcome, and you
are merely trading on the terminology of the global revolution
in child health promotion. This prominent display is both
disingenuous and misleading.
I have criticisms of the methods employed to answer
questions on infant feeding in HIV, and the authors’
interpretation of their results. I will deal only with the latter.
The single most important inference they draw from their
findings is that formula feeding for infants of HIV-infected
women is feasible and safe in urban environments with
sufficient potable water.
However the evaluation of ‘urban environments’ is far more
complicated than their methods allow,2 and one may have rural
settings where there is access to ‘sufficient potable’ water. Their
data do not assist in deciding what is ‘sufficient’, so the key
resource they identify is ‘potable water’.
The Nairobi (urban) randomised controlled trial of breast-
versus  formula-feeding in infants of HIV-infected mothers3
shows the weakness of their postulate. Mortality, and the
incidence of diarrhoea, pneumonia and other illnesses were
similar in both the breast- and formula-fed arms; nutrition was
496
